RT @CochraneAus: New #Cochrane review weighs up benefits and risks of #PARPinhibitors for the treatment of epithelial ovarian cancer http:/…
The latest Cochrane Review asks: Do PARP inhibitors improve survival in women w/ovarian cancer? http://t.co/GATYsZYlNJ #saveCochraneCanada
RT @CochraneLibrary: Do PARP inhibitors improve survival in women with ovarian cancer? What are the side effects? http://t.co/likBnddiwn
#Rev_Sist #Cochrane Inhibidores de la poli ADP-ribosa polimerasa en #cáncer_de_ovario http://t.co/yl5mGqpbw0 @_SEOM @eloisabayo @sefh_
New #Cochrane review weighs up benefits and risks of #PARPinhibitors for the treatment of epithelial ovarian cancer http://t.co/GLxGk7TKD9
Do PARP inhibitors improve survival in women with ovarian cancer? What are the side effects? New #CochraneEvidence: http://t.co/hJ5xQ4fonN
Do PARP inhibitors improve survival in women with ovarian cancer? What are the side effects? New #CochraneEvidence: http://t.co/hJ5xQ4fonN
Do PARP inhibitors improve survival in women with ovarian cancer? What are the side effects? New #CochraneEvidence: http://t.co/hJ5xQ4fonN
Do PARP inhibitors improve survival in women with ovarian cancer? What are the side effects? New #CochraneEvidence: http://t.co/hJ5xQ4fonN
PARP inhibitors appear to improve PFS in women with recurrent platinum-sensitive ovarian cancer http://t.co/VAuUXjQY1V
Do PARP inhibitors improve survival in women with ovarian cancer? What are the side effects? New #CochraneEvidence: http://t.co/hJ5xQ4fonN
Poly(ADP-ribose) polymerase (PARP) inhibitors for the treatment of ovarian cancer http://t.co/12fLGsCSLB #ovariancancer
Evidence shows new medication used to treat women with advanced ovarian cancer is effective in some women http://t.co/VAuUXjQY1V